Virus-Like Particles Expressing Toxoplasma gondii Rhoptry Protein 18 Induces Better Protection Than Rhoptry Protein 4 against T. gondii Infection
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Toxoplasma gondii is a ubiquitous protozoan parasite responsible for causing toxoplasmosis. Preventive mea- sures for toxoplasmosis are currently lacking and as such, development of novel vaccines are of urgent need. In this study, we generated 2 virus-like particles (VLPs) vaccines expressing T. gondii rhoptry protein 4 (ROP4) or rhoptry protein 18 (ROP18) using influenza matrix protein (M1) as a core protein. Mice were intranasally immunized with VLPs vaccines and after the last immunization, mice were challenged with ME49 cysts. Protective efficacy was assessed and compared by determining serum antibody responses, body weight changes and the reduction of cyst counts in the brain. ROP18 VLPs-immunized mice induced greater levels of IgG and IgA antibody responses than those immunized with ROP4 VLPs. ROP18 VLPs immunization significantly reduced body weight loss and the number of brain cysts in mice compared to ROP4 VLPs post-challenge. These results indicate that T. gondii ROP18 VLPs elicited better protective efficacy than ROP4 VLPs, providing important insight into vaccine design strategy.
Abstract
Toxoplasma gondii is a ubiquitous protozoan parasite responsible for causing toxoplasmosis. Preventive mea- sures for toxoplasmosis are currently lacking and as such, development of novel vaccines are of urgent need. In this study, we generated 2 virus-like particles (VLPs) vaccines expressing T. gondii rhoptry protein 4 (ROP4) or rhoptry protein 18 (ROP18) using influenza matrix protein (M1) as a core protein. Mice were intranasally immunized with VLPs vaccines and after the last immunization, mice were challenged with ME49 cysts. Protective efficacy was assessed and compared by determining serum antibody responses, body weight changes and the reduction of cyst counts in the brain. ROP18 VLPs-immunized mice induced greater levels of IgG and IgA antibody responses than those immunized with ROP4 VLPs. ROP18 VLPs immunization significantly reduced body weight loss and the number of brain cysts in mice compared to ROP4 VLPs post-challenge. These results indicate that T. gondii ROP18 VLPs elicited better protective efficacy than ROP4 VLPs, providing important insight into vaccine design strategy.
참고문헌 (20)
- Parlog A, "Toxoplasma gondii-induced neuronal alterations", Parasite Immunol, 37, pp.159~170 (2015)
- Tenter AM, "Toxoplasma gondii: from animals to humans", Int J Parasitol, 30, pp.1217~1258 (2000)
- Jones JL, "Neglected parasitic infections in the United States: toxoplasmosis", Am J Trop Med Hyg, 90, pp.794~799 (2014)
- Goldstein EJC, "Management of Toxoplasma gondii infection during pregnancy", Clin Infect Dis, 47, pp.554~566 (2008)
- Liu Q, "Vaccines against Toxoplasma gondii:status, challenges and future directions", Hum Vaccin Immunother, 8, pp.1305~1308 (2012)
- Yuan ZG, "Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18", Vaccine, 29, pp.6614~6619 (2011)
- Kang SM, "Influenza vaccines based on virus-like particles", Virus Res, 143, pp.140~146 (2009)
- Lee DH, "Virus-like nanoparticle vaccine confers protection against Toxoplasma gondii", PLoS One, 11, pp.e0161231~ (2016)
- Lee SH, "Protection induced by virus-like particles containing Toxoplasma gondii microneme protein 8 against highly virulent RH strain of Toxoplasma gondii infection", PLoS One, 12, pp.e0175644~ (2017)
- Lee SH, "Virus-like particle vaccines expressing Toxoplasma gondii rhoptry protein 18 and microneme protein 8 provide enhanced protection", Vaccine, 36, pp.5692~5700 (2018)
- 이수화, "Influenza M1 Virus-Like Particles Consisting of Toxoplasma gondii Rhoptry Protein 4", Parasites, Hosts and Diseases, 55(2), pp.143~148 (2017), 대한기생충학ㆍ열대의학회[DOI]
- Joyce BR, "Phosphorylation of eukaryotic initiation factor-2{alpha} promotes the extracellular survival of obligate intracellular parasite Toxoplasma gondii", Proc Natl Acad Sci USA, 107, pp.17200~17205 (2010)
- Wang PY, "Protective efficacy of a Toxoplasma gondii rhoptry protein 13 plasmid DNA vaccine in mice", Clin Vaccine Immunol, 19, pp.1916~1920 (2012)
- Fang R, "Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB", c mice model, 2010, pp.28, 1803~1807
- Choi HJ, "Stability of influenza vaccine coated onto microneedles", Biomaterials, 33, pp.3756~3769 (2012)
- Wek RC, "Translational control and the unfolded protein response", Antioxid Redox Signal, 9, pp.2357~2371 (2007)
- Fentress SJ, "The secreted kinase ROP18 defends Toxoplasma's border", Bioessays, 33, pp.693~700 (2011)
- Dorfmeier CL, "Reinvestigating the role of IgM in rabies virus postexposure vaccination", J Virol, 87, pp.9217~9222 (2013)
- Racine R, "IgM in microbial infections: taken for granted?", Immunol Lett, 125, pp.79~85 (2009)
- Perrone LA, "Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge", J Virol, 83, pp.5726~5734 (2009)